gene,ensembl,snp,chromosome,position,variant,region,andean_(n=36),tibetan_(n=27),1000_genomes,notes,literature,ref,alt,denisovan,neandertal,base_change
PPARG,ENSG00000132170,rs4684847,3,12386337,3_12386337,5'UTR  intronic,21,0,6.99%,loss of function; associated with CVD  diabetes  and hypertension,https://www.ncbi.nlm.nih.gov/snp/rs4684847#publications,C,T,C,X,C>C/T
PPARG,ENSG00000132170,rs1801282,3,12393125,3_12393125,exonic,21,0,7.03%,CG variant (what most of our Andeans have) associated with lower rates of OSA in Han Chinese. Part of same haplotype as above (including others in intronic  promoter region); IVA marks as gain of function,https://link.springer.com/article/10.1007/s11325-019-01855-x,C,G,C,C,C>C/G
PPARG,ENSG00000132170,rs2920502,3,12329195,3_12329195,intronic,19,NA,40.54%,decreased risk of diabetes,https://www.ncbi.nlm.nih.gov/pubmed/29849618?dopt=Abstract,G,C,G,X,T>C/G (perhaps the T allele is no longer found in populations?)
PPARGC1A,ENSG00000109819,rs3774923,4,23795064,4_23795064,3'UTR  ncRNA,12,12,9.53%,Linked to diabetes; in LD w/ rs3736265 below,NA,C,T,C,C,C>C/T
PPARGC1A,ENSG00000109819,rs3736265,4, 23814707,4_23814707,Exonic  ncRNA,12,14,10.942,tons of lit; missense; T2D  hypertension  CVD,https://www.ncbi.nlm.nih.gov/snp/rs3736265#publications,G,A,G,G,G>A/T/G
PPARGC1A,ENSG00000109819,rs3755863,4,23815522,4_23815522,exonic  ncRNA,15,15,35.22%,tons of lit; diabetes  fatty liver disease  CVD  etc.; synonymous mutation,NA,C,T,C,C,C>A/G/T
PPARGC1A,ENSG00000109819,rs8192678,4,23815662,4_23815662,exonic  ncRNA,11,14,26.58%,Obesity  diabetes,NA,C,T,C,X,C>T/C*
RORC,ENSG00000143365,rs9826,1,151778899,1_151778899,3'UTR  promoter,17,NA,26.20%,bipolar disorder and cancer,NA,T,C,T,T,T>C/T*
RORC,ENSG00000143365,rs3828057,1,151780177,1_151780177,intronic  promoter,12,NA,28.51%,cancer,NA,C,T,C,C,C>C/T
RORC,ENSG00000143365,rs3811419,1,151805819,1_151805819,promoter,20,3,11.12%,no literature,NA,C,T,C,X,C>G/T/C
PIK3R3,ENSG00000117461,rs11548677,1,46507668,1_46507668,3'UTR  ncRNA,21,NA,4.453,no publications,NA,T,C,T,T,T>T/C*
PIK3R4,ENSG00000196455,rs7536272,1,46643093,1_46643093,intronic  promoter,27,NA,34.265,associated with gastric cancer,NA,A,G,G,A,A>A/G (or G>A/G  NCBI says A>G while Genome Browser says G>A  possibly because certain genomes such as Chimps and Orangutans have Gs while macques have an A so researchers are unsure which is the ancestral and which is derived?)
TXN,ENSG00000136810,rs749384,9,113020678,9_113020678,promoter,19,NA,26,no literature,NA,G,A ,G,G ,G>A/G
SLC8A3,ENSG00000100678,rs76092308,14,70514699,14_70514699,3'UTR  intronic,26,0,3.734,20% in Americans,NA,A,T,A,A,A>A/T
KCNMA1,ENSG00000156113,rs3781141,10,78662861,10_78662861,intronic  ncRNA,22,NA,11.12,NA,NA,G,A,G,X,G>A/G
KCNMA1,ENSG00000156113,rs11001958,10,78740277,10_78740277,intronic  ncRNA,21,18,7.867,no literature,NA,T,C,T,T,T>C/T 
KCNMA1,ENSG00000156113,rs1318421,10,78744521,10_78744521,Intronic,21,18,7.867,probably part of haplotype above  same number in Andeans and Tibetans,NA,T,C,T,T,T>T/C*
KCNMA1,ENSG00000156113,rs10509384,10,79023182,10_79023182,intronic,24,NA,17.47,association with LDL  unsure which direction,https://www.ncbi.nlm.nih.gov/pubmed/17903299,A,G,A,A,A>A/G
KCNMA1,ENSG00000156113,rs12414699,10,79344995,10_79344995,intronic  promoter,21,NA,1.637,11% in Americans  no literature,NA,C,G,C,C,C>C/G
UCN3,ENSG00000178473,rs10904481,10,5415954,10_5415954,exonic,17,NA,NA,not reported previously,NA,A,G,G,G,G>A/G
UCN3,ENSG00000178473,rs10904482,10,5416202,10_5416202,3'UTR,21,NA,NA,not reported previously,NA,G,A,G,X,G>A/G 
DDAH1,ENSG00000153904,rs11161597,1,85784936,1_85784936,3'UTR  intronic,20,NA,14.257,no literature  20% in Americans and Europeans,NA,G,A,G,X,G>G/A*
DDAH1,ENSG00000153904,rs233112,1,85785751,1_85785751,3'UTR  intronic,25,13,37.28,link to diabetes and hypertension  part of very obvious haplotype,NA,T,C,C,T,T>T/C*
DDAH1,ENSG00000153904,rs17590006,1,85789270,1_85789270,intronic,20,11,14.796,link to diabetes,NA,A,G,A,X,A>A/G
DDAH1,ENSG00000153904,rs1498373,1,85790633,1_85790633,intronic,25,NA,27.955,diabetes,NA,G,A,G,X,G>A/G*
DDAH1,ENSG00000153904,rs2230820,1,85816134,1_85816134,exonic  intronic,20,NA,12.46,pre-eclampsia in American Indians (quick look at publication couldn't find SNP),NA,T,C,T,X,T>T/C*
DDAH1,ENSG00000153904,rs12118950,1,85864519,1_85864519,intronic  ncRNA,20,NA,12.939,no literature,NA,T,C,T,T,T>C/T
DDAH1,ENSG00000153904,rs12402128,1,85864711,1_85864711,intronic  ncRNA,20,NA,23.642,no literature,NA,T,C,T,T,T>C/T
DDAH1,ENSG00000153904,rs12758237,1,85870783,1_85870783,intronic  promoter,20,NA,12.899,NA,NA,G,A,G,G,G>A/G
DDAH1,ENSG00000153904,rs17387935,1,85871701,1_85871701,intronic  promoter,20,NA,14.657,in 11 Tibetans  no literature,NA,A,G,A,A,A>A/G
DDAH1,ENSG00000153904,rs12130380,1,85901309,1_85901309,intronic  promoter,20,NA,18.191,in 9 Tibetans  no literature,NA,T,C,C,C,T>T/C
DDAH1,ENSG00000153904,rs12736004,1,85901367,1_85901367,intronic  promoter,20,NA,12.859,same haplotype as above,NA,G,A,G,G,G>A/G
DDAH1,ENSG00000153904,rs61223539,1,85931843,1_85931843,intronic  promoter,17,NA,19.748,no literature,NA,T,C,T,T,T>C/T
DDAH1,ENSG00000153904,rs55639236,1,85932800,1_85932800,intronic  promoter,17,NA,10.903,no literature,NA,G,A/T,G,G,G>A/G/T
DDAH1,ENSG00000153904,rs4420136,1,85975076,1_85975076,intronic,24,NA,15.994,no literature; part of larger haplotype,NA,C,T,C,X,C>C/T
ABAT,ENSG00000183044,rs28398424,16,8766774,16_8766774,promoter,22,NA,9.006,no literature; 4 tibetans,NA,A,G,A,A,A>A/G
ABAT,ENSG00000183044,rs113885001,16,8767255,16_8767255,promoter,21,NA,7.847,no literature; probably part of haplotype above,NA,G,C,G,G,G>G/C
ABAT,ENSG00000183044,rs12921061,16,8777117,16_8777117,intronic  ncRNA,26,NA,12.38,no literature; 3 tibetans,NA,C,A,C,C,C>A/C
ABAT,ENSG00000183044,rs79548259,16,8812836,16_8812836,intronic  promoter,23,NA,3.494,22.22% of Latino,NA,T,A,T,T,T>A/T
ACVRL1,ENSG00000139567,NA,12,52299259,12_52299259,promoter,27,NA,NA,not reported previously; 0 tibetans,NA,G,T,T,T,T>G/T
ATP1B1,ENSG00000143153,rs10919071,1,169099483,1_169099483,intronic,21,NA,8.027,bunch of publications about ethnicity,NA,A,G,A,X,A>A/G
CYBA,ENSG00000051523,rs80283791,16,88718447,16_88718447,3'UTR  promoter,13,NA,1.478,NA,NA,C,T,C,C,C>C/T
CYBA,ENSG00000051523,rs8854,16,88718865,16_88718865,3'UTR  promoter,9,NA,7.728,literature on links to hypertension  OSA  kidney function,NA,C,T,C,C,C>C/T
TEK,ENSG00000120156,rs10967719,9,27108810,9_27108810,promoter,24,NA,22.125,no literature  17 tibetans,NA,G,T,G,G,G>G/T  
TEK,ENSG00000120156,rs139767335,9,27210401,9_27210401,intronic  ncRNA,18,NA,1.697,closer to 10% in Americans; no literature,NA,C,A,C,C,C>A/C
TEK,ENSG00000120156,rs3737188,9,27213580,9_27213580,3'UTR  exonic,15,12,15.375,clinical significance found benign,NA,T,C,T,T,T>T/C*
EP300,ENSG00000100393,rs183526882,22,41487871,22_41487871,5'UTR  promoter,16,NA,1.218,closer to 8% in Americans  no literature,NA,C,T,C,C,C>C/T
EPAS1,ENSG00000116016,rs4953342,2,46552047,2_46552047,intronic,28,8,30.272,previously identified for tibetan adaptation?,NA,A,G,A,A,A>A/G
EPAS1,ENSG00000116016,rs4953344,2,46552458,2_46552458,intronic,23,2,12.54,previouisly identified for tibetans?,NA,T,C,T,T,T>T/C
EPAS1,ENSG00000116016,rs11125070,2,46552926,2_46552926,intronic,22,NA,17.272,hypoxia relation to cancer  5 tibetans,NA,A,G/T,A,A,A>G/T/A  
EPAS1,ENSG00000116016,rs1868084,2,46570708,2_46570708,intronic,22,NA,12.6,hypoxia relation to cancer  5 tibetans; part of haplotype?,NA,C,G,C,X,C>C/G
EPAS1,ENSG00000116016,rs4953354,2,46575388,2_46575388,intronic,28,23,22.464,23 tibetans  hypoxia adaptation (lots of papers but all in Tibetans),NA,A,G,G,G/C,A>A/G
EPAS1,ENSG00000116016,rs10187368,2,46577644,2_46577644,intronic,28,NA,17.991,previously identified by Bigham et al.; part of larger haplotype,NA,G,A,G,G,G>G/A*
EPAS1,ENSG00000116016,rs570553380,2,46588031,2_46588031,exonic,8,NA,0.24,previously identified by Eichstaedt et al.,NA,A,G,A,A,A>A/G
PSMD14,ENSG00000115233,rs147829125,2,162196787,2_162196787,intronic,17,NA,4.473,2 tibetans  no previous literature,NA,C,T,C,C,C>C/T
PSMD14,ENSG00000115233,rs11886577,2,162251437,2_162251437,intronic,21,NA,32.568,20 tibetans  no previous literature,NA,T,C,T,X,T>C/T
PSMD14,ENSG00000115233,rs16845844,2,162265270,2_162265270,intronic  promoter,8,NA,22.784,20 tibetans  no previous literature  part of larger haplotype,NA,A,G,A,A,A>A/G
ETS1,ENSG00000134954,rs1128334,11,128328959,11_128328959,3'UTR,9,NA,17.133,gain of function; 3 tibetans; linked to autoimmune disorders,NA,C,T,C,X,C>C/T*
ETS1,ENSG00000134954,rs73029056,11,128342944,11_128342944,intronic,13,NA,14.337,in 12 tibetans; no previous literature,NA,G,A,G,G,G>A/G
ETS1,ENSG00000134954,rs11221322,11,128346793,11_128346793,intronic,14,NA,13.638,in 12 tibetans; no previous literature; part of larger ghaplotype,NA,T,C,T,T,T>T/C
ETS1,ENSG00000134954,rs61907765,11,128391937,11_128391937,5'UTR  promoter,11,NA,9.006,no tibetans; cited in celiac disease literature,NA,C,G/T,C,X,C>C/G/T
ETS1,ENSG00000134954,rs12805524,11,128395947,11_128395947,intronic  promoter,12,NA,20.667,18 tibetans,NA,A,G,A,A,A>A/G
ETS1,ENSG00000134954,rs7117118,11,128396738,11_128396738,intronic  ncRNA,12,NA,13.558,4 tibetans; part of haplotype above,NA,A,G,A,A,A>A/G
ETS1,ENSG00000134954,rs73030729,11,128401358,11_128401358,intronic,12,NA,21.765,9 tibetans; no previous literature; part of larger haplotype,NA,G,A,G,G,G>G/A*
UBB,ENSG00000170315,rs1006957,17,16282238,17_16282238,promoter,13,NA,28.854,8 tibetans; part of haplotype with other SNPs in promoter region; no previous literature,NA,G,T,T,T,T>G/T
NOTCH1,ENSG00000148400,rs6563,9,139389184,9_139389184,3'UTR,25,NA,50.459,26 Tibetans,NA,A,G,G,G,G>A/G
NOTCH1,ENSG00000148400,rs3124998,9,139389432,9_139389432,3'UTR,7,NA,5.631,19 tibetans; no previously literature,NA,C,T,C,C,C>C/T
NOTCH1,ENSG00000148400,rs61751489,9,139391338,9_139391338,exonic,18,NA,2.117,0 tibetans; missense,NA,C,T,C,C,C>C/T
NOTCH1,ENSG00000148400,rs76371972,9,139399320,9_139399320,exonic,4,NA,0.699,0 tibetans; missense,NA,C,T,C,C,C>C/T
NOTCH1,ENSG00000148400,rs146815569,9,139422348,9_139422348,intronic,17,NA,2.536,0 tibetans; part of haplotype,NA,C,T,C,T,C>C/T
CDKN1B,ENSG00000111276,rs3759216,12,12868086,12_12868086,promoter,28,NA,38.039,22 tibetans; literature cancer,NA,G,A,G,G,G>A/G
CDKN1B,ENSG00000111276,rs3759217,12,12868452,12_12868452,promoter,17,NA,11.002,2 tibetans; literature cancer,NA,C,T,C,C/T,C>C/T
CDKN1B,ENSG00000111276,rs3093731,12,12871682,12_12871682,intronic  promoter,17,NA,1.138,0 tibetans; no literature,NA,T,C,T,T,T>C/T
CDKN1B,ENSG00000111276,rs4251697,12,12874462,12_12874462,3'UTR,3,NA,3.015,4 tibetans; gain of function; no literature,NA,G,A,G,X,G>G/A
CDKN1B,ENSG00000111276,rs7330,12,12874917,12_12874917,3'UTR,23,NA,62.56,27 tibetans; common variant but associated with age and cancer,NA,C,A,A,C,A>A/C
MYOCD,ENSG00000141052,rs80211270,17,12567731,17_12567731,promoter,14,NA,5.371,12 tibetans; no previous literature,NA,T,C,T,C,T>C/T
MYOCD,ENSG00000141052,rs8071072,17,12568877,17_12568877,promoter,22,NA,37.44,15 tibetans; literature cardiac hyperrophy; part of haplotype,NA,A,T,T,X,T>A/T
MYOCD,ENSG00000141052,rs16946453,17,12608769,17_12608769,intronic  ncRNA,25,NA,4.732,10 tibetans; very clearly part of larger haplotype,NA,T,C,T,X,T>T/C
MYOCD,ENSG00000141052,rs1468492,17,12639485,17_12639485,exonic,9,NA,0.958,0 tibetans; synonymous; no previous literature,NA,G,A,G,G,G>A/G
MYOCD,ENSG00000141052,rs76490220,17,12647729,17_12647729,exonic,4,1,1.877,1 tibetan; missense; no previous literature; part of haplotype,NA,T,C,C,X,C>C/T
MYOCD,ENSG00000141052,rs12449924,17,12664170,17_12664170,intronic  ncRNA,11,8,6.33,no literature; part of larger haplotype,NA,C,T,C,X,C>C/T
MYOCD,ENSG00000141052,rs12937647,17,12670962,17_12670962,3'UTR  intronic,25,3,17.153,no literature,NA,G,T,G,G,G>G/T
PHB2,ENSG00000215021,rs374779752,12,7080212,12_7080212,exonic  ncRNA,0,27,NA,frameshift; loss of function; interesting for tibetans,NA,T,C/G,C; no C duplication,C; no C duplication,G>C/T/G (also labeled as rs17857448  missense in EMG1); C duplication
CD34,ENSG00000174059,rs7572,1,208060009,1_208060009,3'UTR,24,19,29.732,no literature,NA,C,T,C,C,C>C/T
CD34,ENSG00000174059,rs1009897,1,208063505,1_208063505,5'UTR  intronic,26,8,21.506,no literature; part of larger haplotype,NA,G,A,G,G,G>A/G
CASR,ENSG00000036828,rs884086,3,121971709,3_121971709,intronic  ncRNA,18,0,1.677,no literature; 10% of Americans,NA,A,G,A,X,A>A/G*
CASR,ENSG00000036828,rs10934578,3,121977282,3_121977282,intronic,26,19,34.505,associations with calcium sensing; part of larger haplotype,NA,G,T,G,T,T>G/T
CASR,ENSG00000036828,rs12493789,3,121981215,3_121981215,exonic,23,0,2.516,literature  but none on hypoxia,NA,A,G,A,A,A>A/G
CASR,ENSG00000036828,rs7647405,3,122000241,3_122000241,intronic,25,0,8.786,no literature; part of larger haplotype,NA,C,T,C/T*,C,C>C/T
CASR,ENSG00000036828,rs1042636,3,122003769,3_122003769,exonic,24,14,20.647,tons of literature  not on hypoxia,NA,A,G,A,X,A>A/G
CASR,ENSG00000036828,rs4678176,3,122009175,3_122009175,3'UTR,24,14,20.687,part of haplotype above,NA,A,G,A,A,A>A/G
AQP3,ENSG00000165272,rs200785872,9,33441711,9_33441711,3'UTR,21,7,29.712,no literature,NA,A,C,C,X,A>A/C
AQP3,ENSG00000165272,rs16919255,9,33441826,9_33441826,3'UTR,23,8,17.173,no literature,NA,C,A/T,C,C,C>A/T
AQP3,ENSG00000165272,NA,9,33442952,9_33442952,exonic,12,0,34.1,actually ref allele,NA,G,A,A,X,G>A*
AQP3,ENSG00000165272,rs12555686,9,33447547,9_33447547,5'UTR,15,3,7.947,part of haplotype (other SNP in promoter region),NA,G,A/T,G,X,G>A/T/G
AQP3,ENSG00000165272,rs17553719,9,33447579,9_33447579,5'UTR  promoter,15,9,27.356,NA,NA,T,C/G,T,X,T>C/G*
RORA,ENSG00000069667,rs75461420,15,60781040,15_60781040,3'UTR  intronic,23,0,3.055,no literature,NA,C,A,C,C,C>A/C
RORA,ENSG00000069667,rs77984012,15,60783135,15_60783135,3'UTR  intronic,19,0,2.975,no literature,NA,A,G,A,A,A>A/G
RORA,ENSG00000069667,rs17270188,15,60799909,15_60799909,intronic,24,22,30.391,type 2 diabetes in chinese,NA,A,G,A,X,A>A/G
RORA,ENSG00000069667,rs74800820,15,60972325,15_60972325,intronic  ncRNA,10,2,3.954,no literature,NA,A,G,A,A,A>A/G
RORA,ENSG00000069667,rs8027032,15,61002898,15_61002898,intronic,27,24,37.979,no literature,NA,T,C,T,X,C>C/T
RORA,ENSG00000069667,rs17237360,15,61028656,15_61028656,intronic  promoter,13,0,1.198,no literature; 5% in Americans,NA,A,G,A,A,A>A/G
RORA,ENSG00000069667,rs12439253,15,61056592,15_61056592,intronic  promoter,23,4,8.027,no literature,NA,G,T,G,G,G>G/T
RORA,ENSG00000069667,rs62006788,15,61140726,15_61140726,intronic  ncRNA,21,5,14.038,no literature; part of larger haplotype,NA,G,C,G,G,G>C/G
TERT,ENSG00000164362,rs33954691,5,1255520,5_1255520,exonic  ncRNA,25,13,11.781,literature on links to telomere length  cancer,NA,G,A,G,G,G>A/G*
TERT,ENSG00000164362,rs7726159,5,1282319,5_1282319,intronic (gain of function),12,16,32.348,literature on links to telomere length  cancer,NA,C,A,C,C,C>A/C
TERT,ENSG00000164362,rs2736098,5,1294086,5_1294086,exonic  ncRNA,14,12,26.558,literature on links to telomere length  cancer  diabetes,NA,C,T,C,X,C>T/C*
TERT,ENSG00000164362,rs2853669,5,1295349,5_1295349,promoter (gain of function),14,13,29.792,part of haplotype above,NA,A,G,A,X,A>G/A*
RYR2,ENSG00000198626,rs1881548,1,237207189,1_237207189,intronic,25,4,21.186,associated with sudden death in patients with coronary artery disease,NA,A,G,A,A,A>G/A*
RYR2,ENSG00000198626,rs12409033,1,237294111,1_237294111,intronic,21,0,3.215,no literature,NA,G,A,G,X,G>G/A
RYR2,ENSG00000198626,rs151277956,1,237314054,1_237314054,intronic,20,0,1.577,no literature,NA,T,G,T,X,T>G/T
RYR2,ENSG00000198626,rs6670163,1,237536584,1_237536584,intronic,23,15,24.201,associated with diabetes  part of huge haplotype,NA,T,G,T,X,T>T/G
RYR2,ENSG00000198626,rs2805465,1,237719177,1_237719177,intronic  promoter,23,23,39.038,part of haplotype,NA,G,T,G,T,T>G/T
RYR2,ENSG00000198626,rs144876996,1,237829823,1_237829823,exonic,10,0,0.699,synonymous mutation,NA,C,T,C,C,C>C/T
RYR2,ENSG00000198626,rs12594,1,237997087,1_237997087,3'UTR,25,10,24.681,no literature,NA,A,G,A,A,A>G
PSMD7,ENSG00000103035,rs147648066,16,74330156,16_74330156,intronic  promoter,25,0,3.454,no literature  but 20% of Americans,NA,C,A,C,C,C>A/C
ASCL2,ENSG00000183734,rs2072072,11,2290196,11_2290196,3'UTR,23,14,42.093,no literature,NA,C,A/G,C,X,C>A/G
PSMB6,ENSG00000142507,rs114626123,17,4699273,17_4699273,promoter,9,0,13.658,no literature,NA,G,T,G,X,T>G/T
PSMB6,ENSG00000142507,rs75260193,17,4699274,17_4699274,promoter,19,20,35.603,no literature,NA,G,T,G,X,T>G/T
PSMB6,ENSG00000142507,rs3169950,17,4699552,17_4699552,exonic,18,3,26.917,synonymous mutation,NA,G,A/C/T,G,X,G>A/C/T
PSMB6,ENSG00000142507,rs2304974,17,4700993,17_4700993,exonic,7,7,3.494,missense,NA,C,T/G,C,C,C>G/T/C
PSMB6,ENSG00000142507,rs2304975,17,4701019,17_4701019,exonic,12,20,20.507,synonymous mutation,NA,C,T,C,C,C>C/T
PPARD,ENSG00000112033,rs2267664,6,35312254,6_35312254,intronic,16,9,11.821,associated with diabetes; part of larger haplotype,NA,G,A,G,G,G>A/G
PPARD,ENSG00000112033,rs2299869,6,35383432,6_35383432,intronic,29,8,5.012,associated with diabetes  part of larger haplotype,NA,C,T,C,C,C>C/T
ARNT2,ENSG00000172379,rs115320900,15,80736671,15_80736671,intronic  ncRNA,12,13,4.173,no literature; part of larger haplotype,NA,C,T,C,C,C>C/T
ARNT2,ENSG00000172379,rs4778798,15,80770223,15_80770223,intronic,15,25,24.681,no literature; part of larger haplotype,NA,T,C,T,X,T>C/T
ARNT2,ENSG00000172379,rs140860203,15,80781957,15_80781957,intronic,18,0,1.418,no literature,NA,G,A,G,G,G>A/G
ARNT2,ENSG00000172379,rs117677249,15,80879649,15_80879649,intronic,16,1,3.095,no literature; part of larger haplotype,NA,G,A,G,G,G>A/G
ARNT2,ENSG00000172379,rs4072568,15,80884025,15_80884025,exonic,7,0,11.202,missense; literature about obesity,NA,G,A,G,X,G>A/G
ARNT2,ENSG00000172379,rs7172733,15,80886484,15_80886484,3'UTR  intronic,24,12,19.629,no literature; part of larger haplotype,NA,G,A,G/A,G,A>A/G
ARNT2,ENSG00000172379,rs76861207,15,80889548,15_80889548,3'UTR  exonic,10,5,7.668,stop gain mutation; no literature,NA,G,A,G,G,G>A/G
PSMD11,ENSG00000108671,rs2302277,17,30791509,17_30791509,intronic  promoter,21,4,22.464,no literature; part of larger haplotype,NA,C,A/G/T,C,X,C>A/G/T
EGLN1,ENSG00000135766,rs185101343,1,231503569,1_231503569,intronic,16,0,1.278,no literature,NA,T,A,T,X,T>A/T
EGLN1,ENSG00000135766,rs560634812,1,231509427,1_231509427,intronic,24,8,29.133,no literature,NA,T,C,T,T,T>T/C (there is also a deletion  sometimes  here that has led to several other SNPs)
EGLN1,ENSG00000135766,rs7542797,1,231553787,1_231553787,intronic,7,1,14.657,previous literature on HA adaptation,NA,A,C,A,A,A>A/C
EGLN1,ENSG00000135766,rs12097901,1,231557255,1_231557255,exonic,13,20,26.038,previous literature (Heinrich  Lorenzo  etc.); literature seems to support that certain variants found in Tibetans aren't found in Andeans?,NA,C,G,G,X,C>C/G
EGLN1,ENSG00000135766,rs2153364,1,231560220,1_231560220,5'UTR,16,27,29.393,no literature; part of larger haplotype,NA,A,G,A,A,A>A/G
PAK1,ENSG00000149269,rs2729762,11,77033699,11_77033699,3'UTR,14,17,41.494,associated with breast cancer,NA,A,G,A,A,A>A/G*
PAK1,ENSG00000149269,rs2853085,11,77123940,11_77123940,intronic  promoter,13,6,12.56,no literature; part of larger haplotype,NA,C,T,C,C,C>C/T
PAK1,ENSG00000149269,rs78057952,11,77186279,11_77186279,ncRNA  promoter,13,6,15.994,part of haplotype above,NA,A,T,A,A,A>A/T
PRKAA1,ENSG00000132356,rs147350847,5,40761595,5_40761595,3'UTR,14,0,0.938,no literature,NA,T,A,T,X,T>A/T
PRKAA1,ENSG00000132356,rs10035226,5,40798451,5_40798451,5'UTR  promoter,22,3,5.95,no literature,NA,G,A,G,X,G>A/G
AQP1,ENSG00000240583,rs144152021,7,30950711,7_30950711,promoter,20,0,2.037,no literature,NA,G,A/C,G,G,G>A/C
LMNA,ENSG00000160789,rs6703983,1,156052656,1_156052656,intronic  promoter,18,23,37.2,no literature,NA,C,A/G/T,C,C,C>A/G/T
LMNA,ENSG00000160789,rs192585352,1,156095364,1_156095364,intronic  promoter,25,0,1.697,no literature; part of larger haplotype,NA,C,T,C,X,C>C/T
SLC2A8,ENSG00000136856,rs3808836,9,130159059,9_130159059,promoter,11,20,22.764,no literature; part of larger haplotype,NA,C,G,C,C,C>G/C
SLC2A8,ENSG00000136856,rs1138740,9,130165995,9_130165995,5'UTR  exonic  ncRNA,18,3,10.403,associated with cancer?; synonymous mutation,NA,C,T,C,X,C>C/T
PIN1,ENSG00000127445,rs112130401,19,9946142,19_9946142,intronic  promoter,15,3,8.846,no literature,NA,C,T,C,X,C>C/T
PIN1,ENSG00000127445,rs2233682,19,9949152,19_9949152,exonic  ncRNA,15,2,8.387,part of haplotype above and larger haplotype; literature on associations with hep and cancer; synonymous mutation,NA,G,A,G,G,G>G/A
ADAM8,ENSG00000151651,rs2275725,10,135089035,10_135089035,exonic  intronic,0,27,90.315,Weird situation; the ref genome for this gene is mostly in the minority (approx 15%). The Andean variant is clearly part of a large haplotype found in approx 17 of them.,NA,A,G,G,X,G>A/G
TRPC6,ENSG00000137672,rs3824934,11,101454488,11_101454488,5'UTR  promoter,23,14,19.708,gain of function; association with idiopathic pulmonary arterial hypertension,NA,G,C,G,X,G>G/C
P2RX2,NA,rs73481442,12,133194066,12_133194066,promoter,20,13,14.397,no literature,NA,A,G,G,X,G>A/G
P2RX2,NA,rs55716322,12,133198589,12_133198589,3'UTR  ncRNA,18,0,6.39,no literature,NA,C,T,C,X,C>C/T
ITPR2,NA,rs1049382,12,26488957,12_26488957,3'UTR  intronic  promoter,12,5,7.827,no literature; part of larger haplotype,NA,G,A,G,G,G>A/G
ITPR2,NA,rs1122348,12,26494485,12_26494485,intronic,22,0,2.576,no literature,NA,C,T,C,C,C>C/T
ITPR2,NA,rs12424679,12,26518730,12_26518730,intronic,26,0,2.676,no literature,NA,A,T,A,X,A>A/T
ITPR2,NA,rs2230376,12,26732987,12_26732987,exonic,13,5,18.67,synonymous; linked to respiratory disease in elderly men,https://www.ncbi.nlm.nih.gov/pubmed/19409562,G,A,A,G,G>A/G*
ITPR2,NA,rs2230375,12,26733062,12_26733062,exonic,13,5,19.988,no literature; part of haplotype above,NA,T,C,C,T,T>T/C
ITPR2,NA,rs988464943,12,26802137,12_26802137,intronic  ncRNA,17,0,17.565,no literature,NA,A,C/T,A,A,A>C/T
ITPR2,NA,rs2230380,12,26806955,12_26806955,exonic,17,4,12.24,no literature; part of larger haplotype,NA,G,A/C,C/A,G,G>A
ITPR2,NA,rs61747530,12,26986011,12_26986011,5'UTR  promoter,13,6,6.29,no literature; part of larger haplotype within promoter region,NA,G,C/T,G,G,G>C/T/G
EDN1,NA,rs2071942,6,12294993,6_12294993,intronic,11,18,25.759,significantly different between lowlanders and highlanders in India,https://www.ncbi.nlm.nih.gov/pubmed/26373931#,G,A,G,G,A>A/G
EDN1,NA,rs5370,6,12296255,6_12296255,exonic,6,18,24.74,missense mutation (damaging according to SIFT); associated with OSA and diabetes; tons of literature; part of haplotype above,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970865/,G,T,G,G,G>G/T
EDN1,NA,rs2092761,6,12297164,6_12297164,3'UTR,15,0,1.198,no literature,NA,C,T,C/T,X,C>T*
NRP2,NA,rs11678877,2,206545421,2_206545421,promoter,22,19,37.819,no literature; part of larger haplotype with variants in promoter and 5'UTR region,NA,A,G,A,A,A>A/G
NRP2,NA,rs77077950,2,206629114,2_206629114,intronic  promoter,10,10,5.731,no literature,NA,A,T,A,X,A>A/T
NRP2,NA,rs2160328,2,206642337,2_206642337,3'UTR  intronic,18,13,29.553,associated with secondary lymphedema following breast cancer surgery; part of larger haplotype,https://www.ncbi.nlm.nih.gov/pubmed/23613720,G,A,A,G,G>A/G
NRP2,NA,rs15994,2,206662297,2_206662297,3'UTR,22,23,37.061,associated with secondary lymphedema following breast cancer surgery; part of larger haplotype in 3'UTR region,NA,C,G,C,C,C>C/G
CARD16,NA,rs542571,11,104912221,11_104912221,3'UTR  exonic,26,1,21.865,missense mutation; no literature; part of larger haplotype (regions in LD have lit on lymphoma); much more common in Africans (40% and Americans 30%),NA,T,A,A,A,A>A/T
CARD16,NA,rs12806837,11,104971257,11_104971257,exonic  intronic,25,1,10.224,missense mutation; no literature; part of larger haplotype mainly within promoter region,NA,G,A,G,X,G>A/G
HIPK2,NA,rs1616786,7,139249264,7_139249264,3'UTR,25,8,6.11,no literature; more common in east asian (18%) and american (18%); part of larger haplotype also in 3'UTR region,NA,C,T,C,C,C>C/T*
HIPK2,NA,rs73156835,7,139249426,7_139249426,3'UTR,18,1,5.232,no literature; more common in american (14.4%); part of larger haplotype in 3'UTR region,NA,C,T,C,C,C>C/T
PSME4,NA,rs2302878,2,54135936,2_54135936,exonic,14,9,10.523,missense mutation; no litereature; part of haplotype,NA,T,C,T,X,T>C/T
PSME4,NA,rs117296869,2,54198181,2_54198181,5'UTR  promoter,19,10,15.575,no literature; haplotype within promoter region,NA,G,C,G,X,G>A/C/G
SIRT1,NA,rs3740051,10,69644335,10_69644335,promoter,10,16,12.36,tons of literature on diabetes and other diseases; part of haplotype with other variants in promoter region,NA,A,G,A,A,A>A/G
SIRT1,NA,rs2273773,10,69666598,10_69666598,exonic,10,17,12.72,synonymous mutation; part of haplotype above and also associated with bunch of diseases,NA,T,C,T,X,T>C/T
CHCHD2,NA,rs77036114,7,56174351,7_56174351,promoter,15,0,13.678,no literature,NA,C,G,C,X,C>G/C/T
PSMB1,NA,rs1474642,6,170852561,6_170852561,intronic,25,1,11.322,associated with bortezomib-induced peripheral neuropathy.,https://www.ncbi.nlm.nih.gov/pubmed/21228734,A,G,A,A,A>A/G
PSMB1,NA,rs12717,6,170862300,6_170862300,exonic  promoter,26,26,45,associated with Myeloma; part of haplotype  within promoter region,NA,G,C,G,G,G>G/C
TLR2,NA,rs5743709,4,154626402,4_154626402,exonic,28,1,2.676,synonymous mutation; used for ancestral study; 20% frequency in latino,NA,G,A,G,G,G>A/G
CHRNA4,NA,rs183345681,20,61992700,20_61992700,5'UTR  Intronic  Promoter  ncRNA,12,16,31.15,no literature,NA,G,A,A,C,G>A/G/C
CHRNA4,NA,rs6122429,20,61993206,20_61993206,Promoter  ncRNA,10,20,25.379,associations with nicotine and alcohol addiction,NA,C,T,C,C,C?>C/T
CHRNA4,NA,rs7267689,20,61993953,20_61993953,Intronic  Promoter,23,4,9.884,no literature; part of larger haplotype,NA,G,C,G,G,G>C/G
ELOB,NA,rs4036,16,2821525,16_2821525,3'UTR  Exonic,8,3,18.83,no literature; missense mutation,NA,G,A,A,A,A>A/G
ELOB,NA,rs8017,16,2821573,16_2821573,3'UTR  Exonic,25,14,41.374,missense mutation; no literature,NA,C,T,C,T,C>C/T
ELOC,NA,rs138785226,8,74857541,8_74857541,3'UTR  Intronic,19,4,8.167,no literature; part of haplotype within 3'UTR region,NA,A,G,A,A,A>A/G
ELOC,NA,rs10504553,8,74876403,8_74876403,Intronic,10,11,17.951,part of GWAS for insulin sensitivity in Hispanic,https://www.ncbi.nlm.nih.gov/pubmed/19902172,C,T,C,C,C>C/T
ELOC,NA,rs531267074,8,74883114,8_74883114,Intronic  Promoter,15,4,8.107,no literature,NA,A,C,A,X,A>A/C
ELOC,NA,rs4738406,8,74884255,8_74884255,Intronic  Promoter,21,4,18.85,no literature,NA,C,T,C,C,C>C/T
ELOC,NA,rs6990813,8,74884530,8_74884530,Promoter,24,7,28.255,no literature,NA,G,T,T,T,T>G/T
ELOC,NA,rs138704699,8,74885956,8_74885956,Promoter,16,1,2.496,no literature; 12.8% in Americans,NA,C,T,C,X,C>C/T
CREBBP,NA,rs76100714,16,3775978,16_3775978,3'UTR,11,0,0.739,no literature,NA,G,C,G,G,G>C/G
CREBBP,NA,rs129963,16,3796147,16_3796147,Intronic,22,8,30.531,links to cancer; part of larger haplotype wihti intronic region,NA,T,C,T,T,T>T/C or G>C/T
CREBBP,NA,rs62039107,16,3890293,16_3890293,Intronic  Promoter,17,1,11.382,linked to memory in elderly?,https://www.ncbi.nlm.nih.gov/pubmed/25150575,A,G,A,A,A>A/G
CREBBP,NA,rs76353113,16,3890324,16_3890324,Intronic  Promoter,11,0,0.938,4% in americans; no literature,NA,A,T,A,A/T,A>A/T
ENO1,NA,rs2781064,1,8926868,1_8926868,Intronic  Promoter,19,11,31.889,no literature,NA,C,T,T,C,C>T/C 
ENO1,NA,rs17032801,1,8940960,1_8940960,Promoter,21,14,9.405,no literature,NA,A,G,A,A,A>A/G
PSMD3,NA,rs7021,17,38153875,17_38153875,3'UTR,18,20,33.626,potential link to glucose metabolism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217104/,T,A,T,X,T>A/T
VEGFC,NA,rs184576859,4,177701531,4_177701531,Intronic,20,2,1.837,no literature,NA,A,G,A,A,A>A/G
VEGFB,NA,rs1058735,11,64000410,11_64000410,Intronic  Promoter,28,16,15.615,no literature,NA,C,G,C,C,C>C/G
VEGFB,NA,rs12794145,11,64006484,11_64006484,3'UTR  Promoter,28,16,15.555,no literature; same haplotype as above,NA,C,T,C,C,C>C/T
APOLD1,NA,rs7974366,12,12937928,12_12937928,Intronic  Promoter,24,16,28.415,no literature; part of larger haploype within intronic region,NA,A,G,G,G,G>A/G
APOLD1,NA,rs4763876,12,12939892,12_12939892,Exonic,16,1,5.791,missense; no literature,NA,G,A,G,X,G>A/G
APOLD1,NA,rs2110596,12,12940830,12_12940830,3'UTR,25,15,22.045,no literature,NA,T,C,T,T,T>C/T
APOLD1,NA,rs7296177,12,12941567,12_12941567,3'UTR,17,2,5.99,no literature; part of haplotype within 3'UTR region,NA,G,C,G,C,G>C/G
TGFBR2,NA,rs1864616,3,30665228,3_30665228,Intronic,25,10,23.582,Associated with serum cholesterol levels,https://www.ncbi.nlm.nih.gov/pubmed/20066028,G,A,G,G,G>A/G
TGFBR2,NA,rs11709624,3,30666452,3_30666452,Intronic,26,24,38.898,associated with hyptertension in Chinese; part of haplotype w/ one of the variants in intronic/promoter region  no dnSNP ID associated with it,https://www.ncbi.nlm.nih.gov/pubmed/24687999,C,G,C,C,C>C/G
TGFBR2,NA,rs4955212,3,30669358,3_30669358,Intronic  Promoter,25,10,23.922,part of haplotype 2 above; associated with preeclampsia,NA,G,A,G,G,G>A/G
SUV39H2,NA,rs72772432,10,14919474,10_14919474,Promoter,16,1,4.892,no literature; part of haplotype in intronic region and one variant in 3'UTR and one variant in exonic region (synonymous mutation),NA,G,T,G,G,G>G/T
SUV39H2,NA,rs12259906,10,14920102,10_14920102,Promoter  ncRNA,24,17,46.652,no literature; part of haplotype with variants in intronic  3'UTR regions,NA,T,G,G,X,G>G/T
SUV39H2,NA,rs13377078,10,14922023,10_14922023,Intronic  Promoter,20,14,35.024,no literature,NA,A,G,G,G,G>A/G
SUV39H2,NA,rs7907802,10,14940694,10_14940694,3'UTR  Intronic  ncRNA,23,17,36.022,associated with diabetes; part of haplotype 2 above,NA,C,T,T,T,T>C/T
SUV39H2,NA,rs61730323,10,14943176,10_14943176,Exonic  Intronic  ncRNA,17,1,4.673,no literature; part of haplotype 4 above,NA,C,G,C,X,C>A/T/G/C
SUV39H2,NA,rs11594111,10,14945406,10_14945406,3'UTR  Intronic  ncRNA,9,1,5.471,associated with diabetes; part of larger haplotype,https://www.ncbi.nlm.nih.gov/pubmed/21896933,A,G,A,A,A>A/G
ICAM1,NA,rs1799969,19,10394792,19_10394792,Exonic  Intronic,26,0,5.671,tons of literature  including inflammation and cardiovascular disease; missense mutation; 18.350 CADD score,NA,G,A,G,G,G>A/G
FAM162A,NA,rs16833120,3,122128757,3_122128757,3'UTR,20,8,7.388,no literature; part of haplotype with variants in intronic region,NA,T,C,T,T,T>C/T
FABP1,NA,rs2241883,2,88424066,2_88424066,Exonic,22,10,22.324,a lot of literature  including metabolic syndrome; in LD with variant in 3'UTR region,NA,T,C,T,T,T>C/T
TH,NA,rs6357,11,2188238,11_2188238,Exonic  Intronic,11,5,15.455,synonymous mutation; various literature  including hypertension in Han Chinese; haplotype within intronic region,NA,C,T,C,C,C>T/C
TH,NA,rs10840489,11,2192798,11_2192798,Intronic  Promoter,13,2,15.036,only literature on neurotransmitters,NA,C,T,C,X,C>C/T
PSMB3,NA,rs186936679,17,36908048,17_36908048,Promoter,8,0,0.319,no literature,NA,C,A,C,X,C>A/C
PSMB3,NA,rs2019203,17,36908672,17_36908672,Promoter,16,6,29.273,no literature,NA,C,A,C,C,C>A/T/C
CA9,NA,rs2071675,9,35673891,9_35673891,5'UTR  Promoter,18,7,11.961,no literature,NA,G,A,G,G,G>A/G
CA9,NA,rs1048638,9,35681122,9_35681122,3'UTR,26,3,17.372,associations with cancer,NA,C,A,C,X,C>A/C
KCNA5,NA,rs2284136,12,5151998,12_5151998,Promoter,12,18,45.048,association with pulmonary arterial hypertension in European Caucasian population,https://www.ncbi.nlm.nih.gov/pubmed/20556823,C,T,T,X,T>C/T
KCNA5,NA,rs1056468,12,5155663,12_5155663,3'UTR,18,19,21.905,no literature,NA,A,T,A,A,A>A/T
AJUBA,NA,rs12147025,14,23440742,14_23440742,3'UTR,11,10,10.982,no literature,NA,A,G,A,X,A>A/G
BMP2,NA,rs60308736,20,6747064,20_6747064,Promoter,17,1,6.49,no literature,NA,T,C,T,T,T>C/T
BMP2,NA,rs35123420,20,6748599,20_6748599,5'UTR,12,0,3.594,pituitary hormone deficiency; part of haplotype in intronic region and one synonymous exonic mutation,https://www.ncbi.nlm.nih.gov/pubmed/24289245,G,C,G,X,G>G/C
BMP2,NA,rs13037675,20,6759706,20_6759706,Exonic,11,0,4.513,sme as above; synonymous mutation,NA,C,T,C,C/T,C>C/T
BMP2,NA,rs170986,20,6760431,20_6760431,3'UTR,23,1,17.352,pituitary hormone deficiency,NA,C,A,C,X,C>A/C
VCAM1,NA,rs1041163,1,101183825,1_101183825,Promoter,14,7,17.812,associated with many inflammation processes; haplotype within intronic region,https://www.ncbi.nlm.nih.gov/snp/rs1041163#publications,T,C,T,X,T>C/T
VCAM1,NA,rs34199378,1,101197012,1_101197012,Exonic  Intronic,9,0,0.579,missense mutation; no literature,NA,A,G,A,A,A>A/G
VCAM1,NA,rs3176878,1,101203698,1_101203698,Exonic,19,2,12.919,synonymous; linked to gallbladders  rheumatoid arthritis,https://www.ncbi.nlm.nih.gov/snp/rs3176878#publications,C,T,C,C,C>C/T
EGLN3,NA,rs2236563,14,34417716,14_34417716,3'UTR  Intronic,15,7,23.722,mentioned in HA paper on Caucasus,NA,G,A,G,X,G>A/G
SLC8A1,NA,rs6736628,2,40332851,2_40332851,3'UTR  Intronic,22,18,25.639,no lit.; part of large haplotype in 3'UTR and intronic region,NA,G,C,G,G,G>C/G
SLC8A1,NA,rs17025108,2,40335134,2_40335134,3'UTR  Intronic,19,14,13.438,no lit.; part of large haplotype in 3'UTR and intronic region,NA,A,G,A,X,A>A/G
SLC8A1,NA,rs395404,2,40382626,2_40382626,Intronic,23,7,13.299,associated with intermediate blood pressure phenotypes during postural adaptation; part of much larger haplotype within intronic region,https://www.ncbi.nlm.nih.gov/pubmed/23269701,G,C,G,G,G>C/G
SLC8A1,NA,rs373606,2,40391158,2_40391158,Intronic,22,6,8.786,no lit.; part of large haplotype in intronic region,NA,G,T,G,X,G>G/T
SLC8A1,NA,rs141011028,2,40401295,2_40401295,Intronic,14,3,1.218,no lit.; part of large haplotype in intronic region,NA,T,C,T,T,T>C/T
SLC8A1,NA,rs452138,2,40435566,2_40435566,Intronic  Promoter,24,7,16.713,no lit.; part of large haplotype in intronic region,NA,A,G,A,A,A>A/G*
SLC8A1,NA,rs1651356,2,40465401,2_40465401,Intronic,24,2,9.046,no lit.; part of large haplotype in intronic region,NA,C,T,C,C,C>C/T
SLC8A1,NA,rs34409901,2,40510100,2_40510100,Intronic,19,23,21.965,no lit.; part of large haplotype in intronic region,NA,G,A,G,G,G>A/G
SLC8A1,NA,rs72943138,2,40553690,2_40553690,Intronic,20,6,17.712,associated with hypertension; part of larger haplotype within intronic region,https://www.ncbi.nlm.nih.gov/pubmed/20109173,G,C,G,G,G>C/G
SLC8A1,NA,rs4952623,2,40649541,2_40649541,Intronic,15,0,1.078,no lit.; part of large haplotype in intronic region,NA,G,C,G,G,G>C/G
SLC8A1,NA,rs17026003,2,40661457,2_40661457,Intronic,9,9,9.625,associated with hypertension; part of larger haplotype within intronic region,https://www.ncbi.nlm.nih.gov/pubmed/20109173,T,C,T,T,C>C/T
SLC8A1,NA,rs796637504,2,40678887,2_40678887,Intronic,6,0,3.263,no lit.; not part of thousand genomes (percentage is from gnomad),NA,A,T,A,X,A>A/T
SLC8A1,NA,rs2301341,2,40680606,2_40680606,Intronic  Promoter,20,0,4.952,no lit.; part of larger haplotype in intronic and promoter region,NA,G,C,G,G,G>C/G
SLC8A1,NA,rs72613874,2,40739784,2_40739784,Intronic  Promoter,17,14,11.961,no lit.; part of larger haplotype in intronic and promoter region,NA,C,T,C,C,C>C/T
SLC8A1,NA,rs17026155,2,40760283,2_40760283,Intronic,27,9,16.194,no lit.; part of large haplotype in intronic region,NA,C,T,C,X,T>C/T
SLC8A1,NA,rs10198424,2,40796445,2_40796445,Intronic,15,12,15.615,no lit.; part of large haplotype in intronic region,NA,A,C,A,A,C>A/C
DPP4,NA,rs12617656,2,162851147,2_162851147,Intronic,21,24,39.357,associated with T2D in Malaysian; part of large haplotype in intronic region,NA,T,C,T,X,T>C/T
STUB1,NA,rs186848346,16,729116,16_729116,Intronic  Promoter  ncRNA,16,0,1.178,no lit.; part of haplotype wihtin promoter region,NA,A,G,A,A,A>A/G
BNIP3L,NA,rs200336108,8,26257189,8_26257189,Intronic,14,0,0.978,no lit.; part of haplotype within intronic region,NA,T,C,T,T,T>T/C
BNIP3L,NA,rs17055200,8,26269089,8_26269089,3'UTR,25,1,2.855,no lit.,NA,G,A,G,G,G>A/T/G
EGLN2,NA,rs11881124,19,41305740,19_41305740,5'UTR  Intronic,9,8,27.656,identified in int. alt. study,https://www.ncbi.nlm.nih.gov/pubmed/22628534,A,G,A,X,A>A/G
TIGAR,NA,rs3217938,12,4415661,12_4415661,Promoter,20,3,3.035,no lit,NA,C,G,C,C,C>G/C/T
TIGAR,NA,rs4332594,12,4421362,12_4421362,Intronic,23,7,15.276,no lit.; part of large haplotype within intronic region,NA,C,T,C,C,C>C/T
TIGAR,NA,rs4444158,12,4433938,12_4433938,Intronic  ncRNA,17,15,12.021,no lit.; part of larger haplotype within intronic and promoter region,NA,G,A,G,G,G>A/G
TIGAR,NA,rs7309402,12,4459032,12_4459032,Exonic,20,15,27.336,no lit.; synonymous mutation; part of larger haplotype within intronic region,NA,G,A,A,G,G>A/T/G
TIGAR,NA,rs7133330,12,4461485,12_4461485,Exonic,27,5,18.331,no lit.; synonymous mutation; part of larger haplotype within intronic region,NA,G,A,G,G,G>A/G
TIGAR,NA,rs60591544,12,4462681,12_4462681,3'UTR,15,0,12.22,no lit.; part of haplotype within 3'UTR region,NA,G,A,G,X,G>A/C/G
E2F1,NA,rs3213177,20,32264533,20_32264533,3'UTR,17,0,2.835,associated with healthy response in DNA repair against smoking-related lung cancer,https://www.ncbi.nlm.nih.gov/pubmed/21976407?dopt=Abstract,C,A,C,X,C>C/A*
E2F1,NA,rs3213162,20,32270106,20_32270106,Intronic,25,1,4.433,no lit.; part of large haplotype within intronic region,NA,G,A,G,G,G>A/G
STC1,NA,rs1062998,8,23702072,8_23702072,3'UTR,11,3,16.294,associated with hypoxia-inducible sporadic ALS; part of haplotype within 3'UTR and 5'UTR and promoter region,https://www.ncbi.nlm.nih.gov/pubmed/18608101?dopt=Abstract,G,A,G,G,G>A/G
STC1,NA,rs3758088,8,23713676,8_23713676,Promoter,25,9,28.055,no lit.; in LD with variant in promoter region,NA,T,C,C,T,T>C/T
PDK1,NA,rs182346729,2,173418424,2_173418424,Intronic  Promoter,8,0,0.559,no lit.; in LD w/ variant in intronic and 3'UTR region,NA,G,A,G,G,G>A/G
PDK1,NA,rs3765065,2,173420254,2_173420254,Intronic  Promoter  ncRNA,14,10,30.312,no lit.; part of haplotype within intronic and promoter region,NA,T,A,A,T,T>A/T
PDK1,NA,rs77842539,2,173421865,2_173421865,Intronic  Promoter,22,18,18.111,no lit.; part of haplotype within intronic and promoter region,NA,C,T,C,C,C>C/T
PDK1,NA,rs1530865,2,173461090,2_173461090,3'UTR  Intronic,10,10,9.485,no lit.; part of haplotype within 3'UTR and intronic region,NA,G,C,G,G,G>C/G
CXCL12,NA,rs1801157,10,44868257,10_44868257,3'UTR,13,10,18.55,tons of lit. on HIV  cancer  etc.; in LD w/ variants in intronic and promoter region,https://www.ncbi.nlm.nih.gov/snp/rs1801157#publications,C,T,C,X,C>T/C
PSMD12,NA,rs11079691,17,65362552,17_65362552,5'UTR  Exonic,9,10,21.645,no lit.,NA,T,A,T,X,T>A/T
TBX5,NA,rs6489956,12,114792236,12_114792236,3'UTR,15,27,80.831,associated w/ congenital heart disease in Han Chinese; marked by IVA as loss of function; more interested in who doesn't have the variant; part of haplotype within intronic region and 3'UTR,https://www.ncbi.nlm.nih.gov/snp/rs6489956#publications,T,C,C,T,C>C/T
TBX5,NA,rs11067101,12,114844203,12_114844203,Intronic  Promoter,16,17,20.228,associated w/ obesity in Taiwanese,https://www.ncbi.nlm.nih.gov/pubmed/28757710,G,A,G,X,G>A/G
ULBP1,NA,rs4425606,6,150284435,6_150284435,Promoter,14,12,38.878,no lit.; part of huge haplotype within promoter  intronic  ncRNA region,NA,A,G,G,A,G>A/G
ULBP1,NA,rs1762123,6,150288094,6_150288094,Intronic,23,0,17.033,no lit.; in LD with other variant in intronic region,NA,T,C,C,T,T>C/T
MACROD2,NA,rs2295414,20,13975842,20_13975842,5'UTR  Promoter  ncRNA,16,8,18.371,no lit.,NA,C,T,C,X,C>C/T
MACROD2,NA,rs17226859,20,13977213,20_13977213,Intronic  Promoter,24,10,10.144,no lit.,NA,T,G,T,T,T>G/T
MACROD2,NA,rs2990505,20,14066276,20_14066276,Exonic,16,7,25.779,missense mutation; no lit; part of haplotype within intronic  promoter region,NA,C,T,T,X,C>C/T
MACROD2,NA,rs149281359,20,14303912,20_14303912,3'UTR  Intronic,8,0,0.639,no lit.,NA,C,T,C,C,C>C/T
MACROD2,NA,rs6079391,20,14306953,20_14306953,Exonic  Intronic,27,11,26.078,missense mutation; no lit.; part of large haplotype in intronic and 3'UTR region,NA,G,T,G,G,G>G/T
MACROD2,NA,rs761998,20,14309952,20_14309952,5'UTR  Intronic,11,6,14.597,no lit.; in LD w/ one intronic variant,NA,A,G,A,A,A>A/G
MACROD2,NA,rs190396884,20,14319321,20_14319321,Intronic  Promoter,15,0,1.098,no lit.,NA,A,T,A,X,A>A/T
MACROD2,NA,rs184151723,20,14319794,20_14319794,Intronic  Promoter,13,1,0.938,no lit.,NA,T,A,T,T,T>A/T
MACROD2,NA,rs80222266,20,14609390,20_14609390,Intronic  ncRNA,10,0,1.777,no lit.,NA,C,G,G,C,G>C/G
MACROD2,NA,rs6135251,20,14736836,20_14736836,Intronic  Promoter,17,2,6.949,no lit.,NA,T,C,T,T,T>C/T
MACROD2,NA,rs41275412,20,14868844,20_14868844,Intronic  ncRNA,11,11,13.658,no lit.,NA,G,T,G,G,G>G/T
MACROD2,NA,rs41275416,20,14885722,20_14885722,Intronic  ncRNA,15,10,9.964,no lit.,NA,C,A,C,X,C>A/C
MACROD2,NA,rs6135314,20,14911003,20_14911003,Intronic  Promoter,15,10,9.065,no lit.,NA,T,C,T,T,C>C/T
MACROD2,NA,rs77486574,20,15002628,20_15002628,Intronic  Promoter,10,0,6.25,no lit.,NA,A,T,A,X,A>A/T
MACROD2,NA,rs6135572,20,15842367,20_15842367,Intronic  Promoter,22,16,10.903,no lit.,NA,T,C,T,X,T>C/T
MACROD2,NA,rs6131737,20,15873799,20_15873799,Intronic  ncRNA,14,7,9.445,no lit.,NA,A,G,A,X,A>A/G
MACROD2,NA,rs75578931,20,15903934,20_15903934,Intronic  ncRNA,20,11,14.477,no lit.,NA,C,A,A,C,A>A/C
MACROD2,NA,rs112761924,20,15904107,20_15904107,Intronic  Promoter,16,7,9.345,no lit.,NA,A,G,A,A,A>A/G
MACROD2,NA,rs62194199,20,15967719,20_15967719,Exonic  Promoter,7,9,6.09,no lit.; missense mutation,NA,T,C,T,T,T>C/T
MACROD2,NA,rs16997015,20,16031427,20_16031427,3'UTR,10,1,6.609,no lit.; in LD w/ some variants in intronic region,NA,G,C,G,X,A>C/G/A
CLC,NA,rs146776010,19,40225031,19_40225031,Exonic,26,0,1.757,missense mutation; labeled damaging by SIFT; rare variant linked to lupus?; in LD w/ 2 variants in intronic region,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993790/,G,C,G,G,G>C/G
CLC,NA,rs2074928,19,40228879,19_40228879,Promoter,23,22,14.657,no lit.,NA,C,T,C,X,T>C/T
DUOX2,NA,rs56323146,15,45386806,15_45386806,Exonic,25,4,7.049,Synonymous mutation; varying literature; all variants listed below in same haplotype as this,NA,G,C,G,X,G>C/G
DUOX2,NA,rs61730030,15,45393014,15_45393014,Exonic,25,1,3.135,missense mutation; IVA marks as gain of function,NA,G,C,G,X,G>C/G
DUOX2,NA,rs57659670,15,45398438,15_45398438,Exonic,27,11,16.494,missensemutation; IVA marks as loss of function,NA,T,C,C,T,C>C/T
ADRA1B,NA,rs3729604,5,159344461,5_159344461,Exonic  Intronic,11,13,20.188,synonymous mutation; no lit; in LD w/ variants in intronic and promoter region,NA,G,A,G,G,A>A/G
ADRA1B,NA,rs1399923827,5,159366295,5_159366295,Intronic  Promoter,22,0,10.548,no lit.; freq from gnomAD,NA,T,A,T,X,?T>A/T
ADRA1B,NA,rs1292692218,5,159366297,5_159366297,Intronic  Promoter,18,0,4.586,no lit.; freq from gnomAD,NA,T,A,T,X,T>A/T
NRP1,NA,rs2228638,10,33475282,10_33475282,Exonic  ncRNA,23,4,10.942,missense; part of large haplotype within intronic region and 3'UTR region; associated w/ tetralogy of Fallot?,https://www.ncbi.nlm.nih.gov/snp/rs2228638#publications,C,T,C,C,C>T/C
NRP1,NA,rs2269103,10,33499220,10_33499220,Intronic  Promoter,15,23,21.585,no lit. part of haplotype within intronic region,NA,G,T,G,G,G>T/G
NRP1,NA,rs2070303,10,33502240,10_33502240,Exonic  Intronic  ncRNA,15,23,23.482,missense; part of haplotype above; no lit,NA,C,T,T,C,C>T/C
NRP1,NA,rs117525057,10,33502357,10_33502357,Exonic  ncRNA,5,1,0.799,missense; no lit.,NA,G,A,G,G,G>A/G
NRP1,NA,rs11598565,10,33540448,10_33540448,Intronic,25,8,27.316,no lit.; part of haplotype within intronic region,NA,A,G,A,A,A>A/G
NRP1,NA,rs183291398,10,33540472,10_33540472,Intronic,19,0,1.697,no lit.,NA,G,A,G,G,G>A/G
NRP1,NA,rs2070296,10,33552695,10_33552695,5'UTR  Exonic  ncRNA,14,0,28.415,associated w/ macular degeneration; haplotype within intronic region,NA,C,T,C,X,C>G/T/C
NRP1,NA,rs3750733,10,33623251,10_33623251,5'UTR  Exonic  ncRNA,13,5,12.44,synonymous; haplotype within promoter and intronic region; associated w/ metastatic colorectal cancer,NA,G,A,G,X,G>A/G
COX4I1,NA,rs11648858,16,85832292,16_85832292,Intronic  Promoter,8,14,13.598,in LD w/ variant below; no lit.,NA,C,G,NA,NA,NA
COX4I1,NA,rs11557187,16,85834818,16_85834818,5'UTR  Exonic  Promoter,8,11,13.059,missense; associated w/ component of Alzheimer's?,https://www.ncbi.nlm.nih.gov/snp/rs11557187#publications,G,A,NA,NA,NA
COX4I1,NA,rs2075553,16,85839977,16_85839977,3'UTR  Intronic,18,14,53.454,no lit.; part of haplotype within intronic region,NA,G,C,NA,NA,NA
BDNF,NA,rs11030101,11,27680744,11_27680744,5'UTR  Intronic  ncRNA,20,14,27.416,tons of varying lit. surround asthma  ADD  etc.; part of haplotype within intronic region,ncbi.nlm.nih.gov/snp/rs11030101#publications,A,T,NA,NA,NA
BDNF,NA,rs11030102,11,27681596,11_27681596,Intronic  Promoter,9,3,11.422,tons of varying lit. surround asthma  ADD  etc.; part of haplotype within intronic  promoter 5'UTR region,https://www.ncbi.nlm.nih.gov/snp/rs11030102#publications,C,G,NA,NA,NA
BDNF,NA,rs11030103,11,27682333,11_27682333,Intronic  Promoter,25,9,15.435,lit on depression treatment; haplotype within intronic region,https://www.ncbi.nlm.nih.gov/snp/rs11030103#publications,A,G,NA,NA,NA
BDNF,NA,rs142889786,11,27696743,11_27696743,Intronic,16,0,1.138,no lit.; in LD w/ other variants in intronic region,NA,A,G,NA,NA,NA
BDNF,NA,rs61888800,11,27722278,11_27722278,5'UTR  Intronic  Promoter,9,4,11.322,tons of lit. on antidepressants  etc.; part of haplotype within intronic  5'UTR  promoter region,https://www.ncbi.nlm.nih.gov/snp/rs61888800#publications,G,T,NA,NA,NA
F5,NA,rs9332676,1,169482305,1_169482305,3'UTR,17,2,4.533,in LD w/ variant in 3'UTR  exonic  intronic; no lit,NA,G,A,NA,NA,NA
F5,NA,rs6027,1,169483561,1_169483561,Exonic,17,2,4.533,missense  SIFT = damaging; in LD w/ above; various lit. some mentioned in IVA but not NCBI,https://www.ncbi.nlm.nih.gov/snp/rs6027#publications,T,C,NA,NA,NA
F5,NA,rs6010,1,169500210,1_169500210,Exonic,17,6,9.744,synonymous; no lit,NA,T,C,NA,NA,NA
F5,NA,rs9332608,1,169510118,1_169510118,Exonic,16,6,9.405,missense; various lit. but not on NCBI about venous thrombosis and preeclampsia etc,NA,G,A,NA,NA,NA
F5,NA,rs13306334,1,169510139,1_169510139,Exonic,13,25,17.232,missense; no lit.,NA,G,A,NA,NA,NA
F5,NA,rs1800595,1,169510348,1_169510348,Exonic,16,0,4.553,missense; tons of lit (many of it on IVA but not NCBI) including CVD  stroke  etc,https://www.ncbi.nlm.nih.gov/snp/rs1800595#publications,T,C,NA,NA,NA
F5,NA,rs9287090,1,169510380,1_169510380,Exonic,20,1,26.358,synonymous; some lit. but doesn't look relevant,NA,G,A,NA,NA,NA
F5,NA,rs6032,1,169511555,1_169511555,Exonic,22,8,26.278,missense; tons of lit.  most of it venous thrombosis; part of haplotype within intronic and exonic region,https://www.ncbi.nlm.nih.gov/snp/rs6032,T,C,NA,NA,NA
F5,NA,rs6018,1,169511878,1_169511878,Exonic,17,2,4.553,missense  SIFT = damaging; various lit. some mentioned in IVA but not NCBI; in LD w/ variants in exonic and intronic region,NA,T,G,NA,NA,NA
F5,NA,rs6025,1,169519049,1_169519049,Exonic,NA,NA,NA,IVA says 27 Tibetans have C variant but Andeans don't have C variant? NCBI reports C as ref allele at 99% frequency ,NA,NA,NA,NA,NA,NA
F5,NA,rs6020,1,169519112,1_169519112,Exonic,11,24,26.358,missense; tons of lit (many of which is only on IVA),https://www.ncbi.nlm.nih.gov/snp/rs6020#publications,C,T,NA,NA,NA
F5,NA,rs6029,1,169529973,1_169529973,Exonic,23,24,39.876,synonymous; tons of lit. (many of which only in IVA); part of haplotype in intronic and exonic region,https://www.ncbi.nlm.nih.gov/snp/rs6029#publications,C,T,NA,NA,NA
COX4i2,NA,rs73613723,20,30224450,20_30224450,Promoter,15,10,9.405,no lit,NA,T,C,NA,NA,NA
PHOX2B,NA,rs62412180,4,41746477,4_41746477,3'UTR,16,3,5.232,no lit.,NA,T,C,NA,NA,NA
PHOX2B,NA,rs2196822,4,41749265,4_41749265,Intronic  Promoter,19,10,38.099,associated w/ Hirschsprung's disease; part of haplotype in intronic  promoter  3'UTR regions,NA,T,C,NA,NA,NA
MECP2,NA,rs3027928,X,153296046,X_153296046,3'UTR  Exonic,20,0,3.258,synonymous; various lit,https://www.ncbi.nlm.nih.gov/snp/rs3027928#publications,G,A,NA,NA,NA
MAFB,NA,rs58716951,20,39318518,20_39318518,Promoter,12,19,37.839,no lit.; haplotype within promoter region,NA,C,G,NA,NA,NA
GAD1,NA,rs4668324,2,171672981,2_171672981,Promoter  ncRNA,24,16,11.142,no lit.; haplotype within promoter region,NA,A,G,NA,NA,NA
GAD1,NA,rs4667660,2,171673132,2_171673132,5'UTR  Intronic  Promoter,18,1,2.396,no lit.; part of haplotype within ncRNA  5'UTR  intronic region,NA,G,A,NA,NA,NA
GAD1,NA,rs3749034,2,171673475,2_171673475,5'UTR  ncRNA,20,4,17.552,various lit.  including schizophrenia,https://www.ncbi.nlm.nih.gov/snp/rs3749034#publications,G,A,NA,NA,NA
TLX3,NA,rs3806930,5,170736044,5_170736044,Intronic  Promoter,24,10,11.042,associated w/ health phenotype in congenital central hypoventilation syndrome; in LD w/ variant in intronic/promoter region,https://pubmed.ncbi.nlm.nih.gov/12407709/?dopt=Abstract,C,T,NA,NA,NA
TLX3,NA,rs918472,5,170738836,5_170738836,3'UTR,25,24,55.552,no lit,NA,G,A,NA,NA,NA
ADCYAP1,NA,rs2231187,18,909561,18_909561,Exonic  Promoter,20,11,20.248,synonymous; mentioned in paper on bipolar disorder,https://pubmed.ncbi.nlm.nih.gov/18349695/,A,G,NA,NA,NA
CHCHD2,NA,rs77036114,7,56174351,7_56174351,Promoter,15,0,13.678,no lit.; part of haplotype within intronic region,NA,C,G,NA,NA,NA
OR51E2,NA,rs1123990,11,4703321,11_4703321,Exonic,10,5,8.466,synonymous; part of haplotype within 3'UTR  exonic (all synonymous also)  intronic region; no lit.,NA,G,A,NA,NA,NA
OR51E2,NA,rs1505192,11,4712079,11_4712079,Exonic,13,9,16.294,missense; part of haplotype within 3'UTR and intronic region; no lit.,NA,A,G,NA,NA,NA
OR51E2,NA,rs11033352,11,4712353,11_4712353,Exonic,14,4,22.005,missense; part of haplotype within 3'UTR and intronic region; no lit.,NA,T,C,NA,NA,NA
HMOX2,NA,rs25685,16,4556911,16_4556911,Exonic,14,0,8.207,synonymous; possible association w/ aging; large haplotype in intronic  5'UTR  ncRNA  promoter  3'UTR region,https://pubmed.ncbi.nlm.nih.gov/17601350/,G,A,NA,NA,NA
VEGFA,NA,rs58414032,6,43739523,6_43739523,Intronic  Promoter,24,23,32.548,no lit.; in LD w/ variants in intronic region (one of them mentioned in HA studies)  promoter region  5'UTR region,NA,G,C,NA,NA,NA
VEGFA,NA,rs3025039,6,43752536,6_43752536,3'UTR,19,8,13.359,tons of lit.  including related to hypoxia; part of haplotype within 3'UTR  intronic region,https://www.ncbi.nlm.nih.gov/snp/rs3025039#publications,C,T,NA,NA,NA
HK1,NA,rs1108272,10,71060621,10_71060621,Intronic  Promoter,20,16,18.63,no lit.; part of haplotype within promoter and intronic region,NA,C,T,NA,NA,NA
CHRNE,NA,rs9914357,17,4801125,17_4801125,3'UTR  Promoter,24,18,21.526,no lit.,NA,C,G,NA,NA,NA
CHRNE,NA,rs2075763,17,4802685,17_4802685,Intronic  Promoter,22,13,10.623,no lit.,NA,G,A,NA,NA,NA
CHRNE,NA,rs35400274,17,4803711,17_4803711,3'UTR  Exonic  Intronic,15,2,22.165,stop gain; haplotype within exonic  promoter  3'UTR region,NA,G,A,NA,NA,NA
CHRNE,NA,rs4790235,17,4806052,17_4806052,3'UTR  Exonic,17,0,2.835,missense; no lit,NA,C,A,NA,NA,NA
